Tenax Therapeutics (TENX) Shares Issued (2010 - 2026)
Tenax Therapeutics recorded quarterly Shares Issued of $30000.0 in Q1 2026, up 101.71% quarter-over-quarter from -$1.8 million in Q4 2024.
Tenax Therapeutics' Shares Issued history runs 12 years deep, the most recent figure standing at $30000.0 for Q1 2026.
- In Q1 2026, Shares Issued changed N/A year-over-year to $30000.0; the TTM figure through Mar 2026 stood at -$6.4 million (down 265.33% YoY), while the FY2025 annual figure was $15.3 million, up 22397.06% from the prior year.
- Shares Issued came in at $30000.0 for Q1 2026 at Tenax Therapeutics, up from -$1.8 million in the prior quarter.
- In the past five years, Shares Issued ranged from a high of $4.7 million in Q2 2024 to a low of -$4.7 million in Q3 2024.
- A 4-year average of $12507.5 and a median of $15530.0 in 2022 frame the typical range for Shares Issued.
- Across the five-year window, Shares Issued plunged 48242.55% in 2023 and surged 257.32% in 2024, its largest moves.
- Tenax Therapeutics' Shares Issued stood at $1060.0 in 2022, then slumped by 48242.55% to -$510311.0 in 2023, then slumped by 244.72% to -$1.8 million in 2024, then jumped by 101.71% to $30000.0 in 2026.
- According to Business Quant data, Shares Issued over the past three periods registered $30000.0, -$1.8 million, and -$4.7 million for Q1 2026, Q4 2024, and Q3 2024 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 5.40 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 27.00 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 163.10 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 13.16 Mn |
| 10 | Tenax Therapeutics | 542.72 Mn | 542.72 Mn | - | 30,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 30,000.00 |
| Mar 31, 2026 | 30,000.00 |
| Dec 31, 2024 | -1.76 Mn |
| Dec 31, 2024 | -1.76 Mn |
| Sep 30, 2024 | -4.70 Mn |
| Sep 30, 2024 | -4.70 Mn |
| Jun 30, 2024 | 4.70 Mn |
| Jun 30, 2024 | 4.70 Mn |
| Mar 31, 2024 | 1.83 Mn |
| Mar 31, 2024 | 1.83 Mn |
| Dec 31, 2023 | -510,311.00 |
| Dec 31, 2023 | -510,311.00 |
| Mar 31, 2023 | 511,311.00 |
| Mar 31, 2023 | 511,311.00 |
| Dec 31, 2022 | 1,060.00 |
| Dec 31, 2022 | 1,060.00 |
| Sep 30, 2021 | 8.65 Mn |
| Sep 30, 2021 | 8.65 Mn |
| Mar 31, 2021 | 544,651.00 |
| Mar 31, 2021 | 544,651.00 |
| Dec 31, 2020 | 6.97 Mn |
| Dec 31, 2020 | 6.97 Mn |
| Sep 30, 2020 | -439,301.00 |
| Sep 30, 2020 | -439,301.00 |
| Jun 30, 2020 | 2.13 Mn |
| Jun 30, 2020 | 2.13 Mn |
| Mar 31, 2020 | 40.00 |
| Mar 31, 2020 | 40.00 |
| Sep 30, 2019 | -96,500.00 |
| Sep 30, 2019 | -96,500.00 |
| Jun 30, 2019 | 96,500.00 |
| Jun 30, 2019 | 96,500.00 |
| Jul 31, 2014 | 543,998.00 |
| Jul 31, 2014 | 543,998.00 |
| Apr 30, 2014 | 55.04 Mn |
| Apr 30, 2014 | 55.04 Mn |
| Jan 31, 2014 | 6.44 Mn |
| Jan 31, 2014 | 6.44 Mn |
| Oct 31, 2013 | 567,000.00 |
| Oct 31, 2013 | 567,000.00 |
| Apr 30, 2012 | 114,448.00 |
| Apr 30, 2012 | 114,448.00 |
| Jan 31, 2012 | 8.00 Mn |
| Jan 31, 2012 | 8.00 Mn |
| Oct 31, 2011 | 619,181.00 |
| Oct 31, 2011 | 619,181.00 |
| Jul 31, 2010 | 4.90 Mn |
| Jul 31, 2010 | 4.90 Mn |